Spearman, P; Jin, H; Knopp, K; Xiao, P; Gingerich, MC; Kidd, J; Singh, K; Tellier, M; Radziewicz, H; Wu, S; Wang, Z; John, SP; Villinger, FJ; He, B. Intranasal parainfluenza virus type 5 (PIV5)-vectored RSV vaccine is safe and immunogenic in healthy adults in a phase 1 clinical study. Science Advances. 2023; 9:eadj7611.

Singh, K; Le, H. Ebola virus protein VP40 induces accessory cell-mediated activation of human natural killer (NK) cells. Journal of immunology (Baltimore, Md. : 1950). 2023; 210:71.33.

Le, H; Spearman, P; Waggoner, SN; Singh, K. Ebola virus protein VP40 stimulates IL-12- and IL-18-dependent activation of human natural killer cells. JCI insight. 2022; 7.

Xiao, P; Dienger-Stambaugh, K; Chen, X; Wei, H; Phan, S; Beavis, AC; Singh, K; Adhikary, NR D; Tiwari, P; Villinger, F; He, B; Spearman, P. Parainfluenza Virus 5 Priming Followed by SIV/HIV Virus-Like-Particle Boosting Induces Potent and Durable Immune Responses in Nonhuman Primates. Frontiers in Immunology. 2021; 12:623996.

Singh, K; Marasini, B; Chen, X; Ding, L; Wang, JJ; Xiao, P; Villinger, F; Spearman, P. A Bivalent, Spherical Virus-Like Particle Vaccine Enhances Breadth of Immune Responses against Pathogenic Ebola Viruses in Rhesus Macaques. Journal of Virology. 2020; 94.

Furlan, SN; Singh, K; Lopez, C; Tkachev, V; Hunt, DJ; Hibbard, J; Betz, KM; Blazar, BR; Trapnell, C; Kean, LS. IL-2 enhances ex vivo-expanded regulatory T-cell persistence after adoptive transfer. Blood Advances. 2020; 4:1594-1605.